AstraZeneca PLC

Europe’s coronavirus vaccine rollout has been thrust into the spotlight again after Italy blocked a shipment of Oxford-AstraZeneca vaccines to Australia.

The European Commission, the institution leading the purchase agreements, has been blamed for not securing enough vaccines.

Emergent CEO Bob Kramer told CNBC that the company has infrastructure in place to produce Johnson & Johnson and AstraZeneca vaccines around the clock.

Figures in a research paper from Public Health England showed how vaccines can significantly reduce hospitalizations in the elderly.

The first real-world data from the U.K.’s inoculation program has given an insight into how effective vaccines have been against Covid-19.

European officials are coming under increasing pressure to reverse restrictions on who can receive the AstraZeneca Covid vaccine.

U.S. stock futures started the new month moving sharply higher Monday, trying to put a dent in the late February decline.

The stocks making the biggest moves in premarket trading include Hilton Grand Vacations, J&J, NRG Energy, and more.

The European Union needs to be faster in its efforts to vaccinate people against the coronavirus, the 27 heads of state said on Thursday.

Rocket builder Astra is preparing to go public via a SPAC in the second quarter, with CEO Chris Kemp telling CNBC how the company plans to scale its business.

Dr. Peter Hotez warned that people should not become complacent due to dropping Covid cases, especially amid reports of B.1.526 spreading in New York.

The news is a hopeful turning point for poorer countries that risk being left behind in the global race for vaccinations.

“We’ve been in the process of developing a manufacturing process for a vaccine product that we’ve never made before,” Pfizer Chief Business Officer John Young said.

U.K. Prime Minister Boris Johnson on Monday announced his plan for the lifting of lockdown restrictions in England.

The lockdown easing for England will come in a number of steps and will be data dependent at every stage, the British prime minister said.

The U.S. Food and Drug Administration is expected to authorize Johnson & Johnson’s vaccine in the coming weeks.

CEO Adar Poonawalla made the announcement over Twitter but did not explain who gave the direction.

Even before COVID-19, India produced up to about 60% of the world’s vaccines and can do so at a relatively low cost.

Check out the companies making headlines in midday trading.

The rollout of COVID-19 vaccines has been slower and more difficult than Americans had hoped, plagued by an undersupply that the Biden administration is trying to overcome. The new administration announced on Feb. 11 that it had finalized a deal to buy 200 million more doses of the Pfizer BioNTech and Moderna versions of the vaccine, the first to receive…